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Pteridines are heterocyclic ompounds which are synthesized and released by human monocytes/macrophages following stimulation by interferon- 
y. Their concentration in various body fluids proved to be indicative for the stimulation of the cellular immune system, and determination of 
pteridines has become an important diagnostic tool. We show that pteridine derivatives, namely neopterin (N), 7&dihydroneopterin (NH,), and 
5,6,7,8-tetrahydrobiopterin (BH,) increase intracellular calcium (Ca,) in human monocytic ells. Significant increases of Ca, are observed at 10 nmol/l 
NH,, at 100 nmol/l BHI and at 1 moYl N, i.e. at concentrations encountered in vivo. At a concentration of 1 flmoV1, Ca, is increased (from a control 
value of 145 f 7 nmol/l) to 464 f 62 nmol/l (NH,), 340 f 41 nmol/l (BH,) and 344 f 46 nmoY1 (N), respectively. The increase of Ca, depends on 
the presence of extracellular calcium and is likely to be due to activation of a calcium channel. We show that the absence of extracellular calcium 
or the addition of lanthanum ions to the extracellular fluid fully reverses the pteridine-induced increase of Ca,. According to these observations, 
pteridines may mimick the effects of other inflammatory mediators on monocytic cells and seem to be involved in the crosstalk of immunocompetent 
cells. 
Intracellular calcium; Macrophage; Neopterin; Tetrahydrobiopterin; Lanthanum 
1. INTRODUCTION 
Pteridines are pyrazino-pyrimidine compounds 
which are synthesized by the cleavage of guanosine tri- 
phosphate (GTP) catalyzed by the enzyme GTP-cy- 
clohydrolase I [I]. Depending on the enzyme pattern of 
the cell the first intermediate of the biosynthetic path- 
way, 7,8-dihydroneopterin-triphosphate, is either con- 
verted to 7,8_dihydroneopterin and neopterin or to 
5,6,7,8-tetrahydrobiopterin [2], the latter known to be 
an essential cofactor for hydroxylation reactions [3] or 
nitric oxide synthase [4,5]. Neopterin and 7,%dihy- 
droneopterin are produced in excess by human macro- 
phages/monocytes upon activation by interferon-y [6]. 
The diagnostic value of neopterin has been established 
in autoimmune diseases, rejection of transplanted or- 
gans, malignant diseases, infectious diseases such as 
AIDS or hepatitis (reviewed in [7]). While it was evident 
that stimulation of the cellular immune system leads to 
an increase of pteridine biosynthesis and release, a pos- 
sible function of pteridines in the inflammatory process 
remained elusive. The present study has been performed 
to identify cellular effects of pteridines in human mon- 
ocytic cells with characteristics of macrophages (THP-1) 
[8]. Since an increase of intracellular calcium concen- 
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tration was discussed to play a role in the activation of 
macrophages [9,10], the effect of pteridines on intracel- 
lular calcium activity in THP-1 cells was tested for. To 
this end, fura- fluorescence was determined in mon- 
ocytic cells before and during application of neopterin, 
dihydroneopterin and tetrahydrobiopterin. As a result, 
all three pteridines were able to enhance intracellular 
calcium activity at concentrations encountered in vivo. 
2. MATERIALS AND METHODS 
Experiments were performed with the human myelomonocytic ell 
line THP-1 [8] obtained from the American Type Culture Collection 
(Rockville, MD). Cells were grown in RPMI-1640 medium supple- 
mented with 10% heat-inactivated fetal calf serum (FCS), 2 mmol/l 
glutamine, 100 U/ml penicillin and 0.1 ng/ml streptomycin. Cells were 
seeded at a density of 1 x 106/ml and cultured in serum free medium 
for 24 h. Then serum was added (final concentration: 10% FCS) and 
effects of pteridines on the intracellular calcium concentration were 
investigated between 1-8 h after serum supplementation. 
Determinations of intracellular calcium activity were made utilizing 
fura- fluorescence. To this end the cells were incubated for 15 min 
with 2.5 pmol/l fura-2-AM (Molecular Probes, Junction City, OR, 
USA), thereafter fixed on polylysine-coated cover glasses and 
mounted in a perfusion chamber, enabling determination of fluores- 
cence signals at a single cell level. Measurements were made under an 
inverted phase-contrast microscope (IM-35, Zeiss, Germany) 
equipped for epifluorescence and photometry (Hamamatsu, Herrsch- 
ing, Germany) [l I]. Light from a xenon arc lamp (XB075, Osram. 
Berlin, Germany) was directed through a grey filter (nominal trans- 
mission 3.16% Oriel, Darmstadt, Germany), alternatively through a 
340-nm and 380~nm, respectively, interference filter (halfwidth 10 nm, 
Oriel, Darmstadt, Germany) and a diaphragm and was deflected by 
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a dichroic mirror (FT425, Zeiss, Germany) into the objective (Plan- 
Neofluar 63x oil immersion, Zeiss, Germany). The emitted fluores- 
cence was directed through a 420 nm cutoff filter to a photomultiplier 
tube (R4829, Hamamatsu, Herrsching, Germany). To reduce the re- 
gion from which fluorescence was collected a pinhole was placed in 
the image plane of the phototubus (limitation to a circular area of 60 
pm diameter). 
Fluorescence values were corrected for cellular autofluorescence; 
intracellular calcium (Ca,) was calculated from the ratio (I) of the 
fluorescence intensities at the two different excitation wave lengths 
(340 mm380 nm) [12,13]: 
Ca, = & Sfi (R - R,,,YSb, (R,,, - R) 
where R,,, and R,,, are the fluorescence ratios corrected for autofluo- 
rescence at experimental condition, at minimal and maximal calcium 
binding. K,, is the dissociation constant for fura- (= 225), Sfi and Sb, 
are the proportionality coefficients for the fluorescence at 380 nm 
excitation of free and calcium-bound ye, respectively. R,,, and Sf2 
were determined by exposure of the cells to 2 mmol/l Mn” + 20pmolll 
A 23187, R,,, and Sbz after exposure of the cells to either, 20 firno 
digrtonin (Sigma, Munich, Germany) or 20 pmolll A 23187. 
The extracellular perfusate was composed of (all numbers mmol/l): 
114 NaCl, 5.4 KCI, 0.8 MgCl,, 1.2 CaCl,, 0.8 Na?HPO,, 0.2 NaH,PO,, 
20 NaHCO, and 5.5 glucose. The solution was equilibrated with 5% 
carbon dioxide and 95% air (pH 7.4) and experiments were carried 
out at 37°C. 
Applicable data are expressed as arithmetic means f S.E.M. Statis- 
tical analysis was made by paired or unpaired r-test, where applicable. 
Statistically significant differences were assumed at P < 0.05. 
3. RESULTS AND DISCUSSION 
As listed in Table I, intracellular calcium activity ap- 
proaches 145 nmolll in the absence of pteridines, i.e. a 
value within the range reported previously for human 
monocytic cells [14]. The pteridines employed in this 
study, i.e. neopterin (N), dihydroneopterin (NH,), and 
tetrahydrobiopterin (BH,) lead to a rapid, transient in- 
crease of intracellular calcium (Fig. 1). The most effec- 
Table I 
Intracellular calcium concentration in nmoU1 (Ca,) in the absence of 
pteridines (control), in the absence of extracellular calcium (0 Ca”), 
in the presence of 100 pmol/l lanthanum ions (La3’), and in the pres- 
ence of various concentrations of neopterin (N), 7,8-dihydroneopterm 
(NH,), 5,6,7,8_tetrahydrobiopterin (BH,) (n = number of expen- 
ments) 
Condition Ca (n) 
Control 
10 nmol/l N 
100 nmoV1 N 
1 pmol/l N 
10 ,umol/l N 
10 nmolll NH2 
100 nmol/l NH, 
1 pmol/l NH, 
10 pmol/l NH, 
10 nmo)/l BH, 
100 nmol/l BH, 
1 pmol/l BH, 
10 flmol/l BH, 
0 Ca*+ 
0 Ca” + 1 ~molll NH? 
La3+ 
La3’ + 1 pmol/l NH, 
145k 7 40 
210 f 86 4 
251 + 82 4 
344f46 5 
425 f 90 4 
254 f 51 6 
249 k 48 6 
464 + 62 8 
553 + 74 6 
183k24 5 
249 + 35 8 
340 + 41 9 
346 + 23 5 
104 + 10 13 
102 + 11 13 
144a 15 4 
138 + 13 4 
tive pteridine is NH,, followed by BH, and N. The 
concentrations required to obtain significant effects are 
10 nmol/l for NH,, 100 nmol/l for BH, and 1 pmolll for 
N. Such neopterin concentrations are approaches in 
blood during activation of the immune system [7,15,16], 
and local concentrations might even be higher. Accord- 
ingly, the effects of the pteridines on the intracellular 
calcium concentration of monocytic cells may also be 
expected to occur in vivo following activation of the 
COi 
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Fig. 1. Effect of pteridine derivatives on intracellular calcium concentration (Ca,) in human monocytic cells. Original tracings showing the effect 
of 7,8_dihydroneopterin (NH,), 5,6,7,8_tetrahydrobiopterin (BH,), and neopterin (N) (final concentrations 1 pmolll each). 
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Fig. 2. Effect of lanthanum ions (La”, 100 pmolll) on pteridine induced increase of intracellular cat&m concentration (Ca,). Original tracings, 
showing the effect of 1 pmol/l 7,8-dihydroneopterin (NH,) on Ca, in both the presence and absence of lanthan~ ions. 
macrophages by interferon-y. The effect of the pteridi- 
nes is variable, most probably depending on the cell 
cycle and/or differentiation stage of the cells. When cells 
are synchronized by serum deprivation and then stimu- 
lated by the addition of FCS, the pteridine effects on Ca, 
are most pronounced in the Gr phase when cells are also 
differentiated badly (not shown). This is in accordance 
with recent findings demonstrating that calcium effects 
in THP-1 monocytic cells depend on the differentiation 
stage of the cell [17]. As shown for NH, (Table I), the 
pteridine effect on the intracellular calcium concentra- 
tion requires the presence of extracellular calcium. Dep- 
rivation of extracellular calcium by the addition of 
EGTA (1 ~0~) decreases Ca, to some 104 nmol/l. In 
none of the experiments performed NH, (1 pmol/l final 
concentration) was able to induce an increase of Ca, 
under these conditions (Table I). Thus, the presence of 
a pteridine-inducible calcium channel seems to be evi- 
dent since the addition of lanthanum ions (100 pmol/l), 
known to block calcium channels [18], abolishes the 
pteridine-induced increase of Ca, {Table I, Fig. 2). A 
number of mediators of the immune system have been 
reported to increase the intracellular calcium concentra- 
tion, such as interferon-y [ 14,191, the cytokine-stimulat- 
ing pteridine biosynthesis in human monocytes/macro- 
phages [6]. An increase of intracellular calcium has in 
turn been shown to play an important role in the activa- 
tion of human monocytic cells [9,10,14,19,20]. Accord- 
ingly, the ability of pteridine derivatives to increase the 
intracellular calcium concentration in human mon- 
ocytic cells indicates that these macrophage-derived 
substances may be involved in the regulation of cal- 
cium-mediated macrophage activation. 
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